Crocin  ||| S:0 E:7 ||| NNP
protects  ||| S:7 E:16 ||| VBZ
retinal  ||| S:16 E:24 ||| JJ
ganglion  ||| S:24 E:33 ||| NN
cells  ||| S:33 E:39 ||| NNS
against  ||| S:39 E:47 ||| IN
H2O2-induced  ||| S:47 E:60 ||| CD
damage  ||| S:60 E:67 ||| NN
through  ||| S:67 E:75 ||| IN
the  ||| S:75 E:79 ||| DT
mitochondrial  ||| S:79 E:93 ||| JJ
pathway  ||| S:93 E:101 ||| NN
and  ||| S:101 E:105 ||| CC
activation  ||| S:105 E:116 ||| NN
of  ||| S:116 E:119 ||| IN
NF-κB  ||| S:119 E:125 ||| NNP
Glaucoma  ||| S:125 E:134 ||| NNP
is  ||| S:134 E:137 ||| VBZ
a  ||| S:137 E:139 ||| DT
degenerative  ||| S:139 E:152 ||| JJ
nerve  ||| S:152 E:158 ||| NN
disorder  ||| S:158 E:167 ||| NN
that  ||| S:167 E:172 ||| IN
results  ||| S:172 E:180 ||| NNS
in  ||| S:180 E:183 ||| IN
irreversible  ||| S:183 E:196 ||| JJ
blindness ||| S:196 E:205 ||| NN
.  ||| S:205 E:207 ||| .
It  ||| S:207 E:210 ||| PRP
has  ||| S:210 E:214 ||| VBZ
been  ||| S:214 E:219 ||| VBN
reported  ||| S:219 E:228 ||| VBN
that  ||| S:228 E:233 ||| IN
the  ||| S:233 E:237 ||| DT
apoptosis  ||| S:237 E:247 ||| NN
of  ||| S:247 E:250 ||| IN
retinal  ||| S:250 E:258 ||| FW
ganglion  ||| S:258 E:267 ||| FW
cells  ||| S:267 E:273 ||| FW
( ||| S:273 E:274 ||| -LRB-
RGCs ||| S:274 E:278 ||| NNP
)  ||| S:278 E:280 ||| -RRB-
is  ||| S:280 E:283 ||| VBZ
a  ||| S:283 E:285 ||| DT
hallmark  ||| S:285 E:294 ||| NN
of  ||| S:294 E:297 ||| IN
glaucoma ||| S:297 E:305 ||| NN
.  ||| S:305 E:307 ||| .
Oxidative  ||| S:307 E:317 ||| JJ
stress  ||| S:317 E:324 ||| NN
is  ||| S:324 E:327 ||| VBZ
one  ||| S:327 E:331 ||| CD
of  ||| S:331 E:334 ||| IN
the  ||| S:334 E:338 ||| DT
major  ||| S:338 E:344 ||| JJ
factors  ||| S:344 E:352 ||| NNS
that  ||| S:352 E:357 ||| WDT
cause  ||| S:357 E:363 ||| VBP
apoptosis  ||| S:363 E:373 ||| VBN
of  ||| S:373 E:376 ||| IN
RGCs ||| S:376 E:380 ||| JJ
.  ||| S:380 E:382 ||| .
Crocin  ||| S:382 E:389 ||| NNP
has  ||| S:389 E:393 ||| VBZ
many  ||| S:393 E:398 ||| JJ
beneficial  ||| S:398 E:409 ||| JJ
effects ||| S:409 E:416 ||| NNS
,  ||| S:416 E:418 ||| ,
including  ||| S:418 E:428 ||| VBG
antioxidant  ||| S:428 E:440 ||| NNS
and  ||| S:440 E:444 ||| CC
anti-apoptotic  ||| S:444 E:459 ||| JJ
actions ||| S:459 E:466 ||| NNS
.  ||| S:466 E:468 ||| .
However ||| S:468 E:475 ||| RB
,  ||| S:475 E:477 ||| ,
the  ||| S:477 E:481 ||| DT
mechanism  ||| S:481 E:491 ||| NN
by  ||| S:491 E:494 ||| IN
which  ||| S:494 E:500 ||| WDT
crocin  ||| S:500 E:507 ||| VBZ
protects  ||| S:507 E:516 ||| VBN
against  ||| S:516 E:524 ||| IN
oxidative  ||| S:524 E:534 ||| CD
stress‑induced  ||| S:534 E:549 ||| CD
damage  ||| S:549 E:556 ||| NN
to  ||| S:556 E:559 ||| TO
RGCs  ||| S:559 E:564 ||| NNP
remains  ||| S:564 E:572 ||| VBZ
unclear ||| S:572 E:579 ||| JJ
.  ||| S:579 E:581 ||| .
The  ||| S:581 E:585 ||| DT
present  ||| S:585 E:593 ||| JJ
study  ||| S:593 E:599 ||| NN
aimed  ||| S:599 E:605 ||| VBN
to  ||| S:605 E:608 ||| TO
investigate  ||| S:608 E:620 ||| VB
the  ||| S:620 E:624 ||| DT
mechanism  ||| S:624 E:634 ||| NN
by  ||| S:634 E:637 ||| IN
which  ||| S:637 E:643 ||| WDT
crocin  ||| S:643 E:650 ||| VBD
protects  ||| S:650 E:659 ||| CD
RGC-5  ||| S:659 E:665 ||| CD
cells  ||| S:665 E:671 ||| NNS
against  ||| S:671 E:679 ||| IN
H2O2-induced  ||| S:679 E:692 ||| CD
damage ||| S:692 E:698 ||| NN
.  ||| S:698 E:700 ||| .
H2O2  ||| S:700 E:705 ||| NNP
was  ||| S:705 E:709 ||| VBD
used  ||| S:709 E:714 ||| VBN
to  ||| S:714 E:717 ||| TO
establish  ||| S:717 E:727 ||| VB
a  ||| S:727 E:729 ||| DT
model  ||| S:729 E:735 ||| NN
of  ||| S:735 E:738 ||| IN
oxidative  ||| S:738 E:748 ||| JJ
stress  ||| S:748 E:755 ||| NN
injury  ||| S:755 E:762 ||| NN
in  ||| S:762 E:765 ||| IN
RGC-5  ||| S:765 E:771 ||| CD
cells  ||| S:771 E:777 ||| NNS
to  ||| S:777 E:780 ||| TO
mimic  ||| S:780 E:786 ||| VB
the  ||| S:786 E:790 ||| DT
development  ||| S:790 E:802 ||| NN
of  ||| S:802 E:805 ||| IN
glaucoma  ||| S:805 E:814 ||| CD
in vitro ||| S:814 E:822 ||| CD
.  ||| S:822 E:824 ||| .
Different  ||| S:824 E:834 ||| JJ
concentrations  ||| S:834 E:849 ||| NNS
( ||| S:849 E:850 ||| -LRB-
0.1  ||| S:850 E:854 ||| CD
and  ||| S:854 E:858 ||| CC
1 µM ||| S:858 E:862 ||| CD
)  ||| S:862 E:864 ||| -RRB-
of  ||| S:864 E:867 ||| IN
crocin  ||| S:867 E:874 ||| NN
were  ||| S:874 E:879 ||| VBD
added  ||| S:879 E:885 ||| VBN
to  ||| S:885 E:888 ||| TO
test  ||| S:888 E:893 ||| VB
whether  ||| S:893 E:901 ||| IN
crocin  ||| S:901 E:908 ||| NN
was  ||| S:908 E:912 ||| VBD
capable  ||| S:912 E:920 ||| JJ
of  ||| S:920 E:923 ||| IN
protecting  ||| S:923 E:934 ||| VBG
RGCs  ||| S:934 E:939 ||| JJ
from  ||| S:939 E:944 ||| IN
H2O2-induced  ||| S:944 E:957 ||| CD
damage ||| S:957 E:963 ||| NN
.  ||| S:963 E:965 ||| .
WST-1 ||| S:965 E:970 ||| NNP
,  ||| S:970 E:972 ||| ,
lactic  ||| S:972 E:979 ||| FW
dehydrogenase  ||| S:979 E:993 ||| FW
( ||| S:993 E:994 ||| -LRB-
LDH ||| S:994 E:997 ||| NNP
)  ||| S:997 E:999 ||| -RRB-
release  ||| S:999 E:1007 ||| NN
and  ||| S:1007 E:1011 ||| CC
Annexin V ||| S:1011 E:1020 ||| NNP
/ ||| S:1020 E:1021 ||| NNP
FITC  ||| S:1021 E:1026 ||| NNP
assays  ||| S:1026 E:1033 ||| NN
were  ||| S:1033 E:1038 ||| VBD
then  ||| S:1038 E:1043 ||| RB
performed ||| S:1043 E:1052 ||| VBN
.  ||| S:1052 E:1054 ||| .
Levels  ||| S:1054 E:1061 ||| NNS
of  ||| S:1061 E:1064 ||| IN
reactive  ||| S:1064 E:1073 ||| FW
oxygen  ||| S:1073 E:1080 ||| FW
species  ||| S:1080 E:1088 ||| FW
( ||| S:1088 E:1089 ||| -LRB-
ROS ||| S:1089 E:1092 ||| NNP
)  ||| S:1092 E:1094 ||| -RRB-
were  ||| S:1094 E:1099 ||| VBD
detected  ||| S:1099 E:1108 ||| VBN
using  ||| S:1108 E:1114 ||| VBG
a  ||| S:1114 E:1116 ||| DT
ROS  ||| S:1116 E:1120 ||| NNP
assay  ||| S:1120 E:1126 ||| JJ
kit ||| S:1126 E:1129 ||| NN
,  ||| S:1129 E:1131 ||| ,
mitochondrial  ||| S:1131 E:1145 ||| FW
membrane  ||| S:1145 E:1154 ||| FW
potential  ||| S:1154 E:1164 ||| FW
( ||| S:1164 E:1165 ||| -LRB-
ΔΨm ||| S:1165 E:1168 ||| NNP
)  ||| S:1168 E:1170 ||| -RRB-
was  ||| S:1170 E:1174 ||| VBD
analyzed  ||| S:1174 E:1183 ||| VBN
by  ||| S:1183 E:1186 ||| IN
JC-1  ||| S:1186 E:1191 ||| CD
staining ||| S:1191 E:1199 ||| NN
,  ||| S:1199 E:1201 ||| ,
caspase-3  ||| S:1201 E:1211 ||| CD
activity  ||| S:1211 E:1220 ||| NN
was  ||| S:1220 E:1224 ||| VBD
examined  ||| S:1224 E:1233 ||| VBN
using  ||| S:1233 E:1239 ||| VBG
a  ||| S:1239 E:1241 ||| DT
Caspase-3  ||| S:1241 E:1251 ||| JJ
assay  ||| S:1251 E:1257 ||| JJ
kit ||| S:1257 E:1260 ||| NN
,  ||| S:1260 E:1262 ||| ,
and  ||| S:1262 E:1266 ||| CC
the  ||| S:1266 E:1270 ||| DT
protein  ||| S:1270 E:1278 ||| NN
levels  ||| S:1278 E:1285 ||| NNS
of  ||| S:1285 E:1288 ||| IN
Bax ||| S:1288 E:1291 ||| NNP
,  ||| S:1291 E:1293 ||| ,
Bcl-1  ||| S:1293 E:1299 ||| NNP
and  ||| S:1299 E:1303 ||| CC
cytochrome c  ||| S:1303 E:1316 ||| NNP
were  ||| S:1316 E:1321 ||| VBD
measured  ||| S:1321 E:1330 ||| VBN
using  ||| S:1330 E:1336 ||| VBG
western  ||| S:1336 E:1344 ||| JJ
blot  ||| S:1344 E:1349 ||| JJ
analysis ||| S:1349 E:1357 ||| NN
.  ||| S:1357 E:1359 ||| .
In  ||| S:1359 E:1362 ||| IN
addition ||| S:1362 E:1370 ||| NN
,  ||| S:1370 E:1372 ||| ,
the  ||| S:1372 E:1376 ||| DT
protein  ||| S:1376 E:1384 ||| NN
level  ||| S:1384 E:1390 ||| NN
of  ||| S:1390 E:1393 ||| IN
phosphorylated  ||| S:1393 E:1408 ||| JJ
nuclear  ||| S:1408 E:1416 ||| JJ
factor-κB  ||| S:1416 E:1426 ||| NNP
( ||| S:1426 E:1427 ||| -LRB-
p-NF-κB ||| S:1427 E:1434 ||| NNP
)  ||| S:1434 E:1436 ||| -RRB-
p65  ||| S:1436 E:1440 ||| NNP
was  ||| S:1440 E:1444 ||| VBD
also  ||| S:1444 E:1449 ||| RB
evaluated  ||| S:1449 E:1459 ||| VBN
using  ||| S:1459 E:1465 ||| VBG
western  ||| S:1465 E:1473 ||| JJ
blot  ||| S:1473 E:1478 ||| JJ
analysis ||| S:1478 E:1486 ||| NN
.  ||| S:1486 E:1488 ||| .
The  ||| S:1488 E:1492 ||| DT
results  ||| S:1492 E:1500 ||| NNS
showed  ||| S:1500 E:1507 ||| VBD
that  ||| S:1507 E:1512 ||| DT
crocin  ||| S:1512 E:1519 ||| NN
protected  ||| S:1519 E:1529 ||| VBD
RGC-5  ||| S:1529 E:1535 ||| CD
cells  ||| S:1535 E:1541 ||| NNS
from  ||| S:1541 E:1546 ||| IN
apoptosis ||| S:1546 E:1555 ||| NN
,  ||| S:1555 E:1557 ||| ,
decreased  ||| S:1557 E:1567 ||| VBD
LDH  ||| S:1567 E:1571 ||| NNP
release  ||| S:1571 E:1579 ||| NN
and  ||| S:1579 E:1583 ||| CC
enhanced  ||| S:1583 E:1592 ||| JJ
cell  ||| S:1592 E:1597 ||| NN
viability ||| S:1597 E:1606 ||| NN
.  ||| S:1606 E:1608 ||| .
Additional  ||| S:1608 E:1619 ||| JJ
experiments  ||| S:1619 E:1631 ||| NNS
demonstrated  ||| S:1631 E:1644 ||| VBD
that  ||| S:1644 E:1649 ||| DT
crocin  ||| S:1649 E:1656 ||| NN
decreased  ||| S:1656 E:1666 ||| VBD
ROS  ||| S:1666 E:1670 ||| NNP
levels ||| S:1670 E:1676 ||| NNS
,  ||| S:1676 E:1678 ||| ,
increased  ||| S:1678 E:1688 ||| VBD
ΔΨm ||| S:1688 E:1691 ||| JJ
,  ||| S:1691 E:1693 ||| ,
downregulated  ||| S:1693 E:1707 ||| VBG
the  ||| S:1707 E:1711 ||| DT
protein  ||| S:1711 E:1719 ||| NN
expression  ||| S:1719 E:1730 ||| NN
of  ||| S:1730 E:1733 ||| IN
Bax  ||| S:1733 E:1737 ||| NNP
and  ||| S:1737 E:1741 ||| CC
cytochrome c ||| S:1741 E:1753 ||| NNP
,  ||| S:1753 E:1755 ||| ,
promoted  ||| S:1755 E:1764 ||| VBD
Bcl-2  ||| S:1764 E:1770 ||| CD
protein  ||| S:1770 E:1778 ||| NN
expression  ||| S:1778 E:1789 ||| NN
and  ||| S:1789 E:1793 ||| CC
activated  ||| S:1793 E:1803 ||| JJ
NF-κB ||| S:1803 E:1808 ||| NN
.  ||| S:1808 E:1810 ||| .
Taken  ||| S:1810 E:1816 ||| VBN
together ||| S:1816 E:1824 ||| RB
,  ||| S:1824 E:1826 ||| ,
the  ||| S:1826 E:1830 ||| DT
findings  ||| S:1830 E:1839 ||| NNS
of  ||| S:1839 E:1842 ||| IN
this  ||| S:1842 E:1847 ||| DT
study  ||| S:1847 E:1853 ||| NN
indicate  ||| S:1853 E:1862 ||| VBP
that  ||| S:1862 E:1867 ||| DT
crocin  ||| S:1867 E:1874 ||| NN
prevented  ||| S:1874 E:1884 ||| VBD
H2O2‑induced  ||| S:1884 E:1897 ||| CD
damage  ||| S:1897 E:1904 ||| NN
to  ||| S:1904 E:1907 ||| TO
RGCs  ||| S:1907 E:1912 ||| JJ
through  ||| S:1912 E:1920 ||| IN
the  ||| S:1920 E:1924 ||| DT
mitochondrial  ||| S:1924 E:1938 ||| JJ
pathway  ||| S:1938 E:1946 ||| NN
and  ||| S:1946 E:1950 ||| CC
activation  ||| S:1950 E:1961 ||| NN
of  ||| S:1961 E:1964 ||| IN
NF-κB ||| S:1964 E:1969 ||| JJ
.  ||| S:1969 E:1971 ||| .
